Catherine Do
Independent DirectorDr. Catherine Do is Independent Director of Drugs Made In America Acquisition II Corp. from September 24, 2025. She is Independent Director of Drugs Made In America Acquisition Corp. since January 2025. Dr. Do was trained as a medical doctor specializing in Public Health and Epidemiology in France, with a keen interest in molecular epidemiology. Due to the absence of a joint PhD-MD program in France, she paused her residency to earn a master’s in Biostatistics and Clinical Research and a PhD in Molecular Pharmacology. After spending a year at the French Drug Agency (ANSM) as a pharmaco-epidemiologist, Dr. Do pursued her interest in molecular research, undertaking a post-doctoral fellowship in genetics and epigenetics at Columbia University. From 2017 to 2021, she served as an assistant scientist at the Center for Discovery and Innovation at Hackensack University Medical Center. In 2021, to further her expertise in chromatin architecture, she joined NYU Langone Health as an Assistant Professor in Pathology focusing on chromatin architecture, underscoring her central role in the field of drug discovery. Dr. Do earned a master’s in Biostatistics and Clinical Research and a PhD in Cellular and Molecular Pharmacology at Paul Sabatier University in Toulouse, France. She holds MD in Epidemiology at Paul Sabatier University in Toulouse, France.
Positions
- Company NameDrugs Made In America Acquisition Corp.Stock CodeDMAAPositionIndependent DirectorRelated Securities
- Company NameDrugs Made In America Acquisition II Corp.Stock CodeDMIIPositionIndependent DirectorRelated Securities
